12-64464320-AT-ATTT
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_013254.4(TBK1):c.229-5_229-4dupTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0141 in 1,147,622 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00024 ( 0 hom., cov: 0)
Exomes 𝑓: 0.016 ( 0 hom. )
Consequence
TBK1
NM_013254.4 splice_region, intron
NM_013254.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.04
Genes affected
TBK1 (HGNC:11584): (TANK binding kinase 1) The NF-kappa-B (NFKB) complex of proteins is inhibited by I-kappa-B (IKB) proteins, which inactivate NFKB by trapping it in the cytoplasm. Phosphorylation of serine residues on the IKB proteins by IKB kinases marks them for destruction via the ubiquitination pathway, thereby allowing activation and nuclear translocation of the NFKB complex. The protein encoded by this gene is similar to IKB kinases and can mediate NFKB activation in response to certain growth factors. The protein is also an important kinase for antiviral innate immunity response. [provided by RefSeq, Sep 2021]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 12-64464320-A-ATT is Benign according to our data. Variant chr12-64464320-A-ATT is described in ClinVar as [Benign]. Clinvar id is 1981388.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000239 (36/150608) while in subpopulation SAS AF= 0.000419 (2/4774). AF 95% confidence interval is 0.000137. There are 0 homozygotes in gnomad4. There are 16 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High AC in GnomAd4 at 36 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBK1 | NM_013254.4 | c.229-5_229-4dupTT | splice_region_variant, intron_variant | ENST00000331710.10 | NP_037386.1 | |||
TBK1 | XM_005268809.2 | c.229-5_229-4dupTT | splice_region_variant, intron_variant | XP_005268866.1 | ||||
TBK1 | XM_005268810.2 | c.229-5_229-4dupTT | splice_region_variant, intron_variant | XP_005268867.1 | ||||
TBK1 | XR_007063071.1 | n.328-5_328-4dupTT | splice_region_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBK1 | ENST00000331710.10 | c.229-5_229-4dupTT | splice_region_variant, intron_variant | 1 | NM_013254.4 | ENSP00000329967.5 |
Frequencies
GnomAD3 genomes AF: 0.000233 AC: 35AN: 150498Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
35
AN:
150498
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0162 AC: 16166AN: 997014Hom.: 0 Cov.: 29 AF XY: 0.0162 AC XY: 8071AN XY: 497584
GnomAD4 exome
AF:
AC:
16166
AN:
997014
Hom.:
Cov.:
29
AF XY:
AC XY:
8071
AN XY:
497584
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000239 AC: 36AN: 150608Hom.: 0 Cov.: 0 AF XY: 0.000218 AC XY: 16AN XY: 73530
GnomAD4 genome
AF:
AC:
36
AN:
150608
Hom.:
Cov.:
0
AF XY:
AC XY:
16
AN XY:
73530
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 13, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at